Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Non-Current Deffered Revenue (2016 - 2024)

Rockwell Medical filings provide 9 years of Non-Current Deffered Revenue readings, the most recent being $429000.0 for Q4 2024.

  • On a quarterly basis, Non-Current Deffered Revenue fell 9.68% to $429000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $429000.0, a 9.68% decrease, with the full-year FY2024 number at $429000.0, down 9.68% from a year prior.
  • Non-Current Deffered Revenue hit $429000.0 in Q4 2024 for Rockwell Medical, down from $441000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $9.5 million in Q1 2020 to a low of $429000.0 in Q4 2024.
  • Median Non-Current Deffered Revenue over the past 5 years was $4.8 million (2022), compared with a mean of $4.4 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: crashed 89.33% in 2023 and later decreased 9.45% in 2024.
  • Rockwell Medical's Non-Current Deffered Revenue stood at $8.0 million in 2020, then fell by 25.32% to $6.0 million in 2021, then plummeted by 56.57% to $2.6 million in 2022, then crashed by 81.73% to $475000.0 in 2023, then decreased by 9.68% to $429000.0 in 2024.
  • The last three reported values for Non-Current Deffered Revenue were $429000.0 (Q4 2024), $441000.0 (Q3 2024), and $452000.0 (Q2 2024) per Business Quant data.